You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 17, May 1, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  From the Centers for Disease Control and Prevention: Morbidity and Mortality Weekly Report
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Enterobacter sakazakii Infections Associated With the Use of Powdered Infant Formula—Tennessee, 2001

JAMA. 2002;287:2204-2205.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

MMWR. 2002:51:297-300

Enterobacter sakazakii, a gram-negative, rod-shaped bacterium, is a rare cause of invasive infection with high death rates in neonates.1,2 This report summarizes the investigation of a fatal infection associated with E. sakazakii in a hospitalized neonate, which indicated that the infection was associated with the presence of the organism in commercial powdered formula fed to the infant. The implicated batch of formula has been recalled by the manufacturer. Clinicians should be aware of the potential risk for infection from use of nonsterile enteral formula in the neonatal health-care setting.

In April 2001, a male infant (2 lbs, 13 oz [1,270 grams]) was delivered by cesarean section at 33.5 weeks' gestation and was hospitalized in a neonatal intensive care unit (NICU) because of low birthweight, prematurity, and respiratory distress. The infant had fever, tachycardia, decreased vascular perfusion, and neurologic abnormalities (e.g., suspected seizure activity) at 11 days. Cerebrospinal . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Nutrition Therapy in Critically Ill Infants and Children
Skillman and Wischmeyer
JPEN J Parenter Enteral Nutr 2008;32:520-534.
ABSTRACT | FULL TEXT  

Genotypic and Phenotypic Analysis of Enterobacter sakazakii Strains from an Outbreak Resulting in Fatalities in a Neonatal Intensive Care Unit in France
Caubilla-Barron et al.
J. Clin. Microbiol. 2007;45:3979-3985.
ABSTRACT | FULL TEXT  

Effectiveness of Disinfectants in Killing Enterobacter sakazakii in Suspension, Dried on the Surface of Stainless Steel, and in a Biofilm
Kim et al.
Appl. Environ. Microbiol. 2007;73:1256-1265.
ABSTRACT | FULL TEXT  

Comparison of Media for the Isolation of Enterobacter sakazakii
Iversen and Forsythe
Appl. Environ. Microbiol. 2007;73:48-52.
ABSTRACT | FULL TEXT  

Attachment of and Biofilm Formation by Enterobacter sakazakii on Stainless Steel and Enteral Feeding Tubes
Kim et al.
Appl. Environ. Microbiol. 2006;72:5846-5856.
ABSTRACT | FULL TEXT  

Detection of Enterobacter sakazakii in Dried Infant Milk Formula by Cationic-Magnetic-Bead Capture
Mullane et al.
Appl. Environ. Microbiol. 2006;72:6325-6330.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.